GlassScriptPhysician profile
Margaret A Eckel
NPI 1144212325
$4,017.12
in general payments reported to CMS, 2019-2025
39 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.18 · 2020: $441 · 2021: $773 · 2022: $1,058 · 2023: $715 · 2024: $665 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $671.52 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $524.30 | 2020-2025 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $429.69 | 2021-2024 | Qulipta, Vraylar |
| Pfizer INC. | $360.57 | 2020-2025 | |
| Amgen INC. | $357.96 | 2020-2024 | Prolia, Evenity, Otezla |
| Upsher-Smith Laboratories LLC | $156.05 | 2020-2023 | |
| Exact Sciences Corporation | $155.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $121.06 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amarin Pharma, INC. | $107.55 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $107.24 | 2022 | |
| Astellas Pharma US INC | $96.47 | 2020-2024 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $85.13 | 2022 | |
| Eisai INC. | $75.83 | 2021-2022 | |
| Abbott Laboratories | $72.86 | 2020-2023 | Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $72.10 | 2021-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Eckel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.